Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer

Authors

  • Vincent Fradet Department of Surgery (urology), Centre Hospitalier de l’Université de Montréal–Hôpital St-Luc, Montréal, Que.
  • Christiane Gaudreau Department of Microbiology, Centre Hospitalier de l’Université de Montréal–Hôpital St-Luc, Montréal, Que.
  • Paul Perrotte Department of Surgery (urology), Centre Hospitalier de l’Université de Montréal–Hôpital St-Luc, Montréal, Que.
  • Jean Côté Department of Pathology, Centre Hospitalier de l’Université de Montréal–Hôpital St-Luc, Montréal, Que.
  • Jean-Marie Paquin Department of Surgery (urology), Centre Hospitalier de l’Université de Montréal–Hôpital St-Luc, Montréal, Que.

DOI:

https://doi.org/10.5489/cuaj.83

Abstract

Intravesical bacille Calmette-Guérin (BCG) therapy is the most effective treatmentfor high-risk superficial bladder cancer. Severe systemic complications are rare, but may occur in approximately 1% of cases. We report a severe complicationof intravesical BCG: a disseminated Mycobacterium bovis infectionwith biopsy-proven granulomatous hepatitis in a patient with bladder cancer. We also elaborate on the different management alternatives.

Downloads

Download data is not yet available.

Downloads

Published

2012-12-11

How to Cite

Fradet, V., Gaudreau, C., Perrotte, P., Côté, J., & Paquin, J.-M. (2012). Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer. Canadian Urological Association Journal, 1(3). https://doi.org/10.5489/cuaj.83